Chemotherapy and Targeted Therapy

Beyond the AI Hype: Why Verseon Is Betting on Physics to Revolutionize Drug Design Chemistry and Medical abstract blue background . 3d rendering

Beyond the AI Hype: Why Verseon Is Betting on Physics to Revolutionize Drug Design

Laily UPN July 22, 2026

In the fast-paced world of biotechnology, where artificial intelligence (AI) has become the industry’s favorite buzzword, a...

Tempus AI Bolsters Cancer Diagnostics Portfolio with Strategic Acquisition of Personalis tempus-ai-bolsters-cancer-diagnostics-portfolio-with-strategic-acquisition-of-personalis

Tempus AI Bolsters Cancer Diagnostics Portfolio with Strategic Acquisition of Personalis

Raul Delapena Setiawan July 22, 2026

By Elise Reuter Published July 20, 2026 In a move that signals a significant consolidation in the...

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin insuring-the-psychedelic-frontier-navigating-the-liability-landscape-of-fda-approved-psilocybin-1

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

Nana Wu July 22, 2026

For over half a century, psilocybin has languished in the shadow of the 1970 Controlled Substances Act,...

The Weight-Loss Wars: Novo Nordisk Escalates Legal Battle Against Eli Lilly Over Advertising Claims the-weight-loss-wars-novo-nordisk-escalates-legal-battle-against-eli-lilly-over-advertising-claims

The Weight-Loss Wars: Novo Nordisk Escalates Legal Battle Against Eli Lilly Over Advertising Claims

Laily UPN July 21, 2026

By Industry Desk July 21, 2026 The fierce rivalry between the two titans of the GLP-1 obesity...

Weekly HIV Treatment Breakthrough: Gilead and Merck’s Oral Regimen Poised to Transform Patient Care weekly-hiv-treatment-breakthrough-gilead-and-mercks-oral-regimen-poised-to-transform-patient-care

Weekly HIV Treatment Breakthrough: Gilead and Merck’s Oral Regimen Poised to Transform Patient Care

Ammar Sabilarrohman July 21, 2026

The landscape of HIV treatment is on the precipice of a significant paradigm shift. For decades, the...

The Billion-Dollar Arms Race: Bristol Myers Squibb Challenges Pharma Giants with Next-Gen AI Supercomputing the-billion-dollar-arms-race-bristol-myers-squibb-challenges-pharma-giants-with-next-gen-ai-supercomputing

The Billion-Dollar Arms Race: Bristol Myers Squibb Challenges Pharma Giants with Next-Gen AI Supercomputing

Ammar Sabilarrohman July 21, 2026

In a decisive move that underscores the escalating importance of artificial intelligence in drug discovery, Bristol Myers...

From Protocol to Patient: Decoding the High-Stakes World of Clinical Supply Chains from-protocol-to-patient-decoding-the-high-stakes-world-of-clinical-supply-chains

From Protocol to Patient: Decoding the High-Stakes World of Clinical Supply Chains

Pevita Pearce July 21, 2026

By BioPharma Dive Editorial Team Published July 20, 2026 The transition from a promising scientific discovery in...

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard in Real-World Evidence beyond-the-hunch-why-rigorous-matching-is-the-new-gold-standard-in-real-world-evidence

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard in Real-World Evidence

Dwi Wanna July 21, 2026

In the modern clinical landscape, the intersection of patient data and medical insight is becoming increasingly complex....

The Reshaping of Biopharma: AI Supremacy, Strategic Acquisitions, and Clinical Milestones the-reshaping-of-biopharma-ai-supremacy-strategic-acquisitions-and-clinical-milestones

The Reshaping of Biopharma: AI Supremacy, Strategic Acquisitions, and Clinical Milestones

Lina Irawan July 20, 2026

In an industry defined by relentless innovation and high-stakes capital allocation, the landscape of global biotechnology and...

Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus race-against-time-cepi-fast-tracks-three-vaccine-candidates-to-combat-bundibugyo-ebolavirus

Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

Nana Muazin July 20, 2026

In an urgent response to the burgeoning Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the...

Chemotherapy and Targeted Therapy

Beyond the AI Hype: Why Verseon Is Betting on Physics to Revolutionize Drug Design

Tempus AI Bolsters Cancer Diagnostics Portfolio with Strategic Acquisition of Personalis

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

The Weight-Loss Wars: Novo Nordisk Escalates Legal Battle Against Eli Lilly Over Advertising Claims

Weekly HIV Treatment Breakthrough: Gilead and Merck’s Oral Regimen Poised to Transform Patient Care

The Billion-Dollar Arms Race: Bristol Myers Squibb Challenges Pharma Giants with Next-Gen AI Supercomputing

From Protocol to Patient: Decoding the High-Stakes World of Clinical Supply Chains

Beyond the Hunch: Why Rigorous Matching is the New Gold Standard in Real-World Evidence

The Reshaping of Biopharma: AI Supremacy, Strategic Acquisitions, and Clinical Milestones

Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

You may have missed

Mastering the Gravity-Defying Flow: The Art of the Ashtanga Jump-Back

Cultivating Prosperity: The BRIDGES Engine and the Future of Rural Agriculture

A Lifesaving Breakthrough for BRCA Carriers: Cambridge Study Confirms Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk

The Pan-Viral Frontier: Can Cocrystal Pharma Rewrite the Rules of Antiviral Development?